Your browser doesn't support javascript.
loading
Real-world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all-case postmarketing surveillance in Japan.
Yamazaki, Naoya; Shimizu, Akiko; Ozaki, Masahiko; Hamada, Masahiro; Takeuchi, Noriko; Ito, Yuichiro; Maekawa, Shinichiroh.
Affiliation
  • Yamazaki N; National Cancer Center Hospital, Tokyo, Japan.
  • Shimizu A; Oncology Medical Affairs, MSD K.K., Tokyo, Japan.
  • Ozaki M; Japan Pharmacovigilance, MSD K.K., Tokyo, Japan.
  • Hamada M; Japan Pharmacovigilance, MSD K.K., Tokyo, Japan.
  • Takeuchi N; Japan Pharmacovigilance, MSD K.K., Tokyo, Japan.
  • Ito Y; Oncology Medical Affairs, MSD K.K., Tokyo, Japan.
  • Maekawa S; Japan Pharmacovigilance, MSD K.K., Tokyo, Japan.
J Dermatol ; 49(11): 1096-1105, 2022 Nov.
Article in En | MEDLINE | ID: mdl-35896505
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Observational_studies / Risk_factors_studies / Screening_studies Limits: Aged / Aged80 / Humans Country/Region as subject: Asia Language: En Journal: J Dermatol Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Observational_studies / Risk_factors_studies / Screening_studies Limits: Aged / Aged80 / Humans Country/Region as subject: Asia Language: En Journal: J Dermatol Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom